SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095745
Filing Date
2024-08-13
Accepted
2024-08-13 07:04:05
Documents
70
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20240630.htm   iXBRL 10-Q 1965736
2 EX-31.1 acet-ex31_1.htm EX-31.1 15188
3 EX-31.2 acet-ex31_2.htm EX-31.2 15318
4 EX-32.1 acet-ex32_1.htm EX-32.1 11699
  Complete submission text file 0000950170-24-095745.txt   7707037

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240630.xsd EX-101.SCH 1369383
72 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240630_htm.xml XML 1049220
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 241198731
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)